SEARCH
YOUR SEARCH FOR Text 163 RESULTS
31 of Total
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… View all news Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs April 30, …
Read More
32 of Total
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… View all news Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs August 2, …
Read More
33 of Total
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… View all news Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs August 1, …
Read More
34 of Total
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… View all news Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs October 31, …
Read More
35 of Total
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativ
… View all news Incyte Announces New Positive 54-Week … Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy …
Read More
36 of Total
Incyte Reports 2021 Fourth Quarter and Year-End Financial Results, and Provides 2022 Financial Guida
… View all news Incyte Reports 2021 Fourth Quarter and Year-End Financial Results, and Provides 2022 Financial Guidance and Updates on Key …
Read More
37 of Total
Incyte Announces Executive Leadership Appointments
… Incyte Announces Executive Leadership Appointments …
Read More
38 of Total
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
… Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates …
Read More
39 of Total
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativ
… Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativ …
Read More
40 of Total
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
… Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs …
Read More